C2i Genomics
C2i Genomics is now part of Veracyte. We encourage you to follow Veracyte on LinkedIn.
26 employees · est. 2019 · New York, United States
Veracyte, Inc.
Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.
753 employees · est. 2008 · South San Francisco, United...
Veracyte, Inc. is the older company (2019 vs 2008); Veracyte, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | C2i Genomics | Veracyte, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2008 older |
| Headquarters | ||
| Headquarters | New York, United States | South San Francisco, United States |
| Employees | ||
| Employees | 26 | 753 larger |
| Industry | ||
| Industry | Health Care, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | IPO |
| Total Funding | ||
| Total Funding | $112.00M | $1.15B |
| Funding Rounds | ||
| Funding Rounds | 2 | 12 |
| Services | ||
| Services | Not tracked yet | Genomic Sequencing Classifier, Bladder Genomic Classifier, Prostate Genomic Classifier, Breast Risk of Recurrence Test, Monitoring Test for MIBC |
| Target Customers | ||
| Target Customers | Not tracked yet | Clinicians, Cancer Patients, Healthcare Providers, Research Scientists, Oncology Clinics |
| Taxonomy | ||
| Taxonomy | C2i Genomics, Veracyte, Genomics, Medical Diagnostics, Cancer Diagnosis, Acquisition, LinkedIn, Health Technology, Mergers And Acquisitions | Genomic Diagnostics, Cancer Diagnostics, Molecular Diagnostics, Thyroid Cancer Testing, Lung Cancer Testing, Breast Cancer Testing, Idiopathic Pulmonary Fibrosis Testing, Lymphoma Subtyping, Diagnostic Instrument Platform, Patient Care Improvement, Genomic Science Advancements, Cancer Treatment Guidance, Clinical Decision Support, Global Diagnostics Company, Cost-effective Diagnostics |
| Website | ||
| Website | c2i-genomics.com | veracyte.com |
About C2i Genomics
C2i Genomics is a company in the Health Care industry, founded in 2019 and headquartered in the United States. The company recently received a $100.00M Series B investment on April 15, 2021, with participation from notable investors including LionBird, Casdin Capital, iGlobe Partners, Driehaus Capit...
About Veracyte, Inc.
Veracyte, Inc., founded in 2008 and headquartered in the United States, operates within the Biotechnology and Health Care industries. The company's slogan, "Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.," encapsulates its core mission: delivering high-value diagnostic insights that...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at C2i Genomics and Veracyte, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at C2i Genomics and Veracyte, Inc. — by email.
Frequently Asked Questions
Compare C2i Genomics with someone else
Start typing a company name or domain.